Kazia Therapeutics Ltd ADR

Kazia Therapeutics Ltd ADR - Enterprise Valueverified

KZIA

Price:

$12.03

Market Cap:

$28.02M

Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase II trial to treat isocitrate dehydrogenase-mutant glioma, primary central nervous system (CNS) lymphoma, diffuse intrinsic pontine glioma, and brain metastases; and in pre-clinical studies to treat triple-negative breast cancer, as well as for the treatment of atypical rhabdoid/teratoid tumors. It als...[Read more]

Industry

Biotechnology

IPO Date

1999-01-06

Stock Exchange

NASDAQ

Ticker

KZIA

The Enterprise Value as of July 2026 (TTM) for Kazia Therapeutics Ltd ADR (KZIA) is -41273321.94

According to Kazia Therapeutics Ltd ADR’s latest financial reports and current stock price. The company's current Enterprise Value is -41273321.94. This represents a change of 1.81% compared to the average of -2165963.44 of the last 4 quarters.

Kazia Therapeutics Ltd ADR (KZIA) Historical Enterprise Value (quarterly & annually)

How has KZIA Enterprise Value performed in the past?

The mean historical Enterprise Value of Kazia Therapeutics Ltd ADR over the last ten years is 32.39M. The current -41273321.94 Enterprise Value has changed -12840.93% with respect to the historical average. Over the past ten years (40 quarters), KZIA's Enterprise Value was at its highest in in the June 2021 quarter at 145.89M. The Enterprise Value was at its lowest in in the December 2025 quarter at -37083611.79.

Quarterly (TTM)
Annual

Average

32.39M

Median

15.72M

Minimum

6.49M

Maximum

127.10M

Kazia Therapeutics Ltd ADR (KZIA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kazia Therapeutics Ltd ADR Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 343.36%

Maximum Annual Enterprise Value = 127.10M

Minimum Annual Increase = -76.32%

Minimum Annual Enterprise Value = 6.49M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20256.49M-4.36%
20246.78M-76.32%
202328.64M-61.86%
202275.08M-40.93%
2021127.10M343.36%
202028.67M67.30%
201917.14M19.81%
201814.30M70.73%
20178.38M-26.34%
201611.37M50.70%

Kazia Therapeutics Ltd ADR (KZIA) Average Enterprise Value

How has KZIA Enterprise Value performed in the past?

The current Enterprise Value of Kazia Therapeutics Ltd ADR (KZIA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

13.97M

5-year avg

48.82M

10-year avg

32.39M

Kazia Therapeutics Ltd ADR (KZIA) Enterprise Value vs. Peers

How is KZIA’s Enterprise Value compared to its peers?

Kazia Therapeutics Ltd ADR’s Enterprise Value is less than Can-Fite BioPharma Ltd. (8.19B), less than CNS Pharmaceuticals, Inc. (154.38K), less than Silo Pharma, Inc. (950.51K), less than Soligenix, Inc. (-338349.00), less than Biodexa Pharmaceuticals Plc (-7650747.10), less than Clearmind Medicine Inc. (-9161229.00), less than InMed Pharmaceuticals Inc. (-1716209.00), less than GRI Bio, Inc. (-10857947.00), less than Oragenics, Inc. (-3809855.00), greater than Titan Pharmaceuticals, Inc. (-67856311.00),

CompanyEnterprise ValueMarket cap
8.19B$1.72M
154.38K$2.87M
950.51K$4.85M
-338349.00$5.36M
-7650747.10$1.08M
-9161229.00$2.17M
-1716209.00$3.02M
-10857947.00$132.05K
-3809855.00$2.24M
-67856311.00$3.11M

Build a custom stock screener for Kazia Therapeutics Ltd ADR (KZIA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kazia Therapeutics Ltd ADR using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kazia Therapeutics Ltd ADR (KZIA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kazia Therapeutics Ltd ADR or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Kazia Therapeutics Ltd ADR's Enterprise Value?

What is the highest Enterprise Value for Kazia Therapeutics Ltd ADR (KZIA)?

What is the 3-year average Enterprise Value for Kazia Therapeutics Ltd ADR (KZIA)?

What is the 5-year average Enterprise Value for Kazia Therapeutics Ltd ADR (KZIA)?

How does the current Enterprise Value for Kazia Therapeutics Ltd ADR (KZIA) compare to its historical average?